rs16999358

Variant summary

Our verdict is Benign. The variant received -21 ACMG points: 0P and 21B. BP4_StrongBP6_Very_StrongBP7BA1

The NM_001130823.3(DNMT1):​c.996C>T​(p.Asp332Asp) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0024 in 1,611,458 control chromosomes in the GnomAD database, including 87 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.0028 ( 9 hom., cov: 31)
Exomes 𝑓: 0.0024 ( 78 hom. )

Consequence

DNMT1
NM_001130823.3 synonymous

Scores

2

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:4

Conservation

PhyloP100: -0.194

Publications

7 publications found
Variant links:
Genes affected
DNMT1 (HGNC:2976): (DNA methyltransferase 1) This gene encodes an enzyme that transfers methyl groups to cytosine nucleotides of genomic DNA. This protein is the major enzyme responsible for maintaining methylation patterns following DNA replication and shows a preference for hemi-methylated DNA. Methylation of DNA is an important component of mammalian epigenetic gene regulation. Aberrant methylation patterns are found in human tumors and associated with developmental abnormalities. Variation in this gene has been associated with cerebellar ataxia, deafness, and narcolepsy, and neuropathy, hereditary sensory, type IE. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Jan 2016]
DNMT1 Gene-Disease associations (from GenCC):
  • autosomal dominant cerebellar ataxia, deafness and narcolepsy
    Inheritance: AD Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: ClinGen, Genomics England PanelApp, PanelApp Australia, Orphanet, Labcorp Genetics (formerly Invitae)
  • hereditary sensory neuropathy-deafness-dementia syndrome
    Inheritance: AD Classification: STRONG, SUPPORTIVE Submitted by: PanelApp Australia, Labcorp Genetics (formerly Invitae), Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -21 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.63).
BP6
Variant 19-10162679-G-A is Benign according to our data. Variant chr19-10162679-G-A is described in ClinVar as Benign. ClinVar VariationId is 327917.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BP7
Synonymous conserved (PhyloP=-0.194 with no splicing effect.
BA1
GnomAdExome4 highest subpopulation (EAS) allele frequency at 95% confidence interval = 0.0578 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
DNMT1NM_001130823.3 linkc.996C>T p.Asp332Asp synonymous_variant Exon 13 of 41 ENST00000359526.9 NP_001124295.1
DNMT1NM_001318730.2 linkc.948C>T p.Asp316Asp synonymous_variant Exon 12 of 40 NP_001305659.1
DNMT1NM_001379.4 linkc.948C>T p.Asp316Asp synonymous_variant Exon 12 of 40 NP_001370.1
DNMT1NM_001318731.2 linkc.633C>T p.Asp211Asp synonymous_variant Exon 13 of 41 NP_001305660.1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
DNMT1ENST00000359526.9 linkc.996C>T p.Asp332Asp synonymous_variant Exon 13 of 41 1 NM_001130823.3 ENSP00000352516.3

Frequencies

GnomAD3 genomes
AF:
0.00276
AC:
416
AN:
150566
Hom.:
10
Cov.:
31
show subpopulations
Gnomad AFR
AF:
0.0000488
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.000530
Gnomad ASJ
AF:
0.00548
Gnomad EAS
AF:
0.0548
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.00631
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.000501
Gnomad OTH
AF:
0.00339
GnomAD2 exomes
AF:
0.00625
AC:
1570
AN:
251268
AF XY:
0.00583
show subpopulations
Gnomad AFR exome
AF:
0.000185
Gnomad AMR exome
AF:
0.000116
Gnomad ASJ exome
AF:
0.00655
Gnomad EAS exome
AF:
0.0691
Gnomad FIN exome
AF:
0.00636
Gnomad NFE exome
AF:
0.000501
Gnomad OTH exome
AF:
0.00375
GnomAD4 exome
AF:
0.00236
AC:
3454
AN:
1460820
Hom.:
78
Cov.:
34
AF XY:
0.00238
AC XY:
1729
AN XY:
726762
show subpopulations
African (AFR)
AF:
0.000179
AC:
6
AN:
33464
American (AMR)
AF:
0.000112
AC:
5
AN:
44706
Ashkenazi Jewish (ASJ)
AF:
0.00597
AC:
156
AN:
26120
East Asian (EAS)
AF:
0.0598
AC:
2371
AN:
39670
South Asian (SAS)
AF:
0.000406
AC:
35
AN:
86250
European-Finnish (FIN)
AF:
0.00674
AC:
358
AN:
53154
Middle Eastern (MID)
AF:
0.000522
AC:
3
AN:
5750
European-Non Finnish (NFE)
AF:
0.000263
AC:
292
AN:
1111364
Other (OTH)
AF:
0.00378
AC:
228
AN:
60342
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.438
Heterozygous variant carriers
0
177
354
530
707
884
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
50
100
150
200
250
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.00275
AC:
415
AN:
150638
Hom.:
9
Cov.:
31
AF XY:
0.00343
AC XY:
252
AN XY:
73436
show subpopulations
African (AFR)
AF:
0.0000487
AC:
2
AN:
41076
American (AMR)
AF:
0.000529
AC:
8
AN:
15116
Ashkenazi Jewish (ASJ)
AF:
0.00548
AC:
19
AN:
3466
East Asian (EAS)
AF:
0.0548
AC:
282
AN:
5150
South Asian (SAS)
AF:
0.00
AC:
0
AN:
4756
European-Finnish (FIN)
AF:
0.00631
AC:
63
AN:
9988
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
290
European-Non Finnish (NFE)
AF:
0.000501
AC:
34
AN:
67808
Other (OTH)
AF:
0.00336
AC:
7
AN:
2082
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.493
Heterozygous variant carriers
0
17
34
51
68
85
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
10
20
30
40
50
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.00127
Hom.:
2
Bravo
AF:
0.00346
Asia WGS
AF:
0.0150
AC:
52
AN:
3478
EpiCase
AF:
0.000218
EpiControl
AF:
0.000474

ClinVar

Significance: Benign
Submissions summary: Benign:4
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

Hereditary sensory neuropathy-deafness-dementia syndrome Benign:2
Jan 12, 2018
Illumina Laboratory Services, Illumina
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score and internal cut-off values, a variant classified as benign is not then subjected to further curation. The score for this variant resulted in a classification of benign for this disease. -

Jan 13, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

not provided Benign:2
Mar 03, 2015
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.63
CADD
Benign
8.2
DANN
Benign
0.49
PhyloP100
-0.19
RBP_binding_hub_radar
0.0
RBP_regulation_power_radar
2.8
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs16999358; hg19: chr19-10273355; API